Brian Kneafsey Sells 30,000 Shares of Blend Labs, Inc. (NYSE:BLND) Stock

Blend Labs, Inc. (NYSE:BLNDGet Free Report) insider Brian Kneafsey sold 30,000 shares of Blend Labs stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $5.05, for a total transaction of $151,500.00. Following the completion of the sale, the insider now owns 907,439 shares in the company, valued at approximately $4,582,566.95. This trade represents a 3.20 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Brian Kneafsey also recently made the following trade(s):

  • On Tuesday, December 10th, Brian Kneafsey sold 30,000 shares of Blend Labs stock. The stock was sold at an average price of $5.12, for a total transaction of $153,600.00.

Blend Labs Stock Down 6.7 %

BLND stock opened at $4.70 on Thursday. The business has a 50 day moving average of $4.41 and a 200 day moving average of $3.59. The firm has a market cap of $1.20 billion, a PE ratio of -13.82 and a beta of 1.33. Blend Labs, Inc. has a twelve month low of $2.08 and a twelve month high of $5.53.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Wells Fargo & Company boosted their price target on shares of Blend Labs from $4.50 to $6.50 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Canaccord Genuity Group upped their target price on Blend Labs from $4.75 to $5.75 and gave the stock a “buy” rating in a report on Thursday, November 7th. The Goldman Sachs Group raised their target price on Blend Labs from $3.40 to $3.90 and gave the company a “buy” rating in a research note on Thursday, November 7th. JMP Securities assumed coverage on Blend Labs in a research note on Wednesday. They issued an “outperform” rating and a $7.00 price target on the stock. Finally, UBS Group raised their price objective on Blend Labs from $3.00 to $4.00 and gave the company a “neutral” rating in a research report on Wednesday, October 23rd. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $5.11.

Get Our Latest Report on Blend Labs

Hedge Funds Weigh In On Blend Labs

Several institutional investors and hedge funds have recently modified their holdings of the stock. Dark Forest Capital Management LP bought a new position in Blend Labs in the 2nd quarter worth about $31,000. Xponance Inc. purchased a new position in Blend Labs in the second quarter worth about $35,000. Virtu Financial LLC bought a new position in shares of Blend Labs in the third quarter worth approximately $63,000. RiverPark Advisors LLC purchased a new stake in shares of Blend Labs during the third quarter valued at approximately $77,000. Finally, FMR LLC increased its position in shares of Blend Labs by 15.8% during the third quarter. FMR LLC now owns 26,148 shares of the company’s stock valued at $98,000 after acquiring an additional 3,576 shares in the last quarter. 52.56% of the stock is currently owned by institutional investors.

Blend Labs Company Profile

(Get Free Report)

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.

Featured Articles

Insider Buying and Selling by Quarter for Blend Labs (NYSE:BLND)

Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.